Cisatracurium Kabi Storage

Store in a refrigerator (2 - 8°C).
Do not freeze.
Keep ampoules in the outer carton in order to protect from light.
After first opening: The medicinal product should be used immediately after opening the ampoule.
Prepared infusion solution: Chemical and physical in-use stability have been demonstrated for 24 hours at 25°C.
From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2-8°C.
Diluted to concentrations between 0.1 and 2 mg cisatracurium/ml, Cisatracurium Kabi is physically and chemically stable for 24 hours at 25°C in sodium chloride 9 mg/ml (0.9%) solution; in sodium chloride 9 mg/ml (0.9%) and glucose 50 mg/ml (5%) solution; and in glucose 50 mg/ml (5%) solution.
Cisatracurium has been shown to be compatible with the following commonly used peri-operative medicinal products, when mixed in conditions simulating administration into a running intravenous infusion via a Y-site injection port: alfentanil hydrochloride, droperidol, fentanyl citrate, midazolam hydrochloride and sufentanil citrate. Where other agents are administered through the same indwelling needle or cannula as cisatracurium, it is recommended that each medicinal product be flushed through with an adequate volume of a suitable intravenous fluid, e.g., sodium chloride 9 mg/ml (0.9%) solution.
This medicinal product must not be mixed with other medicinal products except those previously mentioned.
Since cisatracurium is stable only in acidic solutions, it should not be mixed in the same syringe or administered simultaneously through the same needle with alkaline solutions, e.g., sodium thiopentone.
It is not compatible with ketorolac trometamol or propofol injectable emulsion.